Secukinumab in refractory non-infectious anterior uveitis

Secukinumab in refractory non-infectious anterior uveitis

BackgroundSecukinumab is a monoclonal antibody that selectively neutralizes interleukin-17A and has shown efficacy in the treatment of psoriatic arthritis, psoriasis, and axial spondyloarthritis. Its use in non-anterior non-infectious uveitis is controversial, with evidence generally not supporting...

Full description

Saved in:
Bibliographic Details
Main Authors: Otto M. Olivas-Vergara, Inés Hernanz, Pablo E. Borges-Deniz, Fredeswinda Romero-Bueno, Olga Sanchez-Pernaute, Ester Carreño
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-02-01
Series:Frontiers in Ophthalmology
Subjects:
secukinumab
anterior uveitis
uveitis
spondyloarthritis
psoriatic arthritis
Online Access:https://www.frontiersin.org/articles/10.3389/fopht.2025.1491981/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items